secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001683168-24-000168
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma provides January 2024 investor presentation; no material new financial data
--------------------------------------------------------------------------------

- Presentation reiterates stabilized HOCl platform for dermatology, wound, eye, nasal, oral, animal health.
- Products sold in 55 countries directly or through distribution partners.
- Company actively seeking additional distribution partners to expand global reach.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824000168/0001683168-24-000168-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824000168/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-000168

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer